Summary
Starwin Products Ghana was a Ghanaian pharmaceutical manufacturer. It was the first pharmaceutical company to be listed on the Ghana Stock Exchange. It was a component of the GSE All-Share Index. The company produced 8 brand name products.
 | |
| Company type | Public limited company |
|---|---|
| GSE: SPL | |
| Industry | Pharmaceutical |
| Founded | 1960 |
| Headquarters | |
Key people | Nik Amarteifio (Chairman) Yaw Opare-Asamoah (CEO) |
| Products | Rapinol, Asmadrin, Painoff, Paraking, milk of magnesia, liver salts |
History edit
Starwin began as the Ghana branch of Sterling Products International in 1960. In 1976, under the Ghanaian government's indigenization program, the company sold 50% of its stock to entrepreneurs in Ghana. In 1987, Sterling, the original company, was bought by Kodak and Starwin Products was born. On January 13, 2004 Starwin became a public limited liability company and in December 2004 the company was listed on the Ghana Stock Exchange.
In January 2020, Starwin Products Limited and two other domestic pharmaceutical companies, Dannex Limited and Ayrton Drug Manufacturing Limited, had already merged and listed on the Ghana Stock Exchange as DAS Pharma.[1]
Operations edit
The company's product line included Rapinol, Asmadrin, Painoff, Paraking, milk of magnesia and liver salts.
References edit
- ^ Bruce, Emmanuel (16 January 2020). "Three local pharmaceutical companies merge lists on GSE as DAS Pharma. Three local pharmaceutical companies, Dannex Limited, Ayrton Drug Manufacturing Limited and Starwin Products Limited have merged and listed on the Ghana Stock Exchange as DAS Pharma". Graphic Online. Graphic Communications Group Ltd. Retrieved 6 December 2020.
External links edit
- DAS Pharma official homepage
- Starwin Products report from Gold Coast Securities - HTML version
- SAS Ghana Brokerage Listings Page
- Starwin Products at Alacrastore